Samsung Electronics is increasingly drawing on its India-based research capabilities to shape global smartphone innovation, with several widely used features originating from its Noida R&D hub. Senior leadership from Samsung Research Institute in Noida confirmed that functionalities such as backup calling and direct voicemail were conceptualized in India and later deployed across global devices.

India’s entrepreneurial ecosystem has achieved a significant milestone, with the government recognizing more than 55,200 startups during FY26—the highest annual addition since the launch of Startup India in 2016. The surge reflects growing innovation, investor confidence, and policy support across sesectors

The initial public offering (IPO) of Citius Transnet Investment Trust witnessed a measured start, garnering 69 percent subscription on the first day of bidding. The offering attracted bids for over 4.23 crore units against an issue size of approximately 6.13 crore units. Notably, the category designated for non-institutional investors surpassed full subscription at 1.16 times, signaling strong interest from individual participants.

National Stock Exchange has received regulatory approval from Securities and Exchange Board of India to invest in the proposed National Coal Exchange of India Ltd, marking a significant step toward formalizing coal trading in India. The initiative aims to create a transparent, efficient marketplace for physical coal transactions, replacing fragmented and opaque systems. The exchange will now seek licensing from the Coal Controller Organisation, advancing the country’s efforts to modernize commodity markets and improve price discovery in one of its most critical energy sectors.

Adani Group is set to invest Rs 1 lakh crore in the large-scale redevelopment of Motilal Nagar in Mumbai, marking one of the most ambitious urban transformation projects in India. Spanning 143 acres in Goregaon, the project will generate approximately 28 lakh square meters of built-up area. Of this, a substantial portion will be allocated to existing residents and authorities, while around 17 lakh square meters will be available for commercial sale.

India’s foreign exchange reserves have staged a strong recovery, rising above the USD 700 billion mark after weeks of volatility triggered by global geopolitical tensions. According to the Reserve Bank of India, reserves increased by USD 3.825 billion to USD 700.946 billion for the week ended April 10. The rebound follows earlier declines linked to currency pressures and market interventions.

India’s equity markets staged a strong rally, with benchmark indices gaining nearly 1 percent as easing geopolitical tensions and declining crude oil prices improved global sentiment. The BSE Sensex rose 504.86 points to close at 78,493.54, while the Nifty 50 advanced 156.80 points to settle at 24,353.55. Renewed diplomatic optimism in global hotspots and increased foreign capital inflows supported the upward momentum.

Lupin Ltd has reached a settlement agreement worth USD 30 million (approximately Rs 250 crore) through its U.S. subsidiary Lupin Pharmaceuticals Inc with Humana Inc, resolving allegations tied to anti-competitive practices. The dispute was part of a broader, consolidated litigation framework in the United States involving multiple pharmaceutical firms. The settlement allows Lupin to mitigate legal uncertainties and refocus on its core business operations, while avoiding prolonged litigation risks in a complex regulatory environment.

Resolution of a Complex Legal Dispute

Aurobindo Pharma has received final approval from the US Food and Drug Administration to manufacture and market a generic version of glycerol phenylbutyrate oral liquid, a treatment for urea cycle disorders. The product, with a strength of 1.1 gram per ml, is therapeutically equivalent to the branded drug Ravicti. With an estimated market size of USD 50.2 million (approximately Rs 420 crore), the approval marks a strategic addition to Aurobindo’s U.S. portfolio, reinforcing its position in niche and specialty therapeutic segments.

Regulatory Milestone Enhances Product Pipeline

India’s gold import bill surged to a record USD 71.98 billion (approximately Rs 6 lakh crore) in FY26, driven primarily by elevated global prices despite a decline in import volumes. According to official data, imports rose 24 percent year-on-year, even as physical quantities fell to 721.03 tonnes. Meanwhile, silver imports witnessed an even sharper rise, jumping nearly 150 percent in value to USD 12 billion (around Rs 1 lakh crore), alongside a 42 percent increase in volume.